Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Outcomes of Heart-Lung Transplantation: Review of 10 Single-Center Consecutive Patients

  • Yun, Jae Kwang (Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine) ;
  • Choi, Se Hoon (Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine) ;
  • Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine)
  • Received : 2015.05.13
  • Accepted : 2015.06.23
  • Published : 2016.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Heart-lung transplantation (HLT) has provided hope to patients with end-stage lung disease and irreversible heart dysfunction. We reviewed the clinical outcomes of 10 patients who underwent heart-lung transplantation at Asan Medical Center. Methods: Between July 2010 and August 2014, a total of 11 patients underwent HLT at Asan Medical Center. After excluding one patient who underwent concomitant liver transplantation, 10 patients were enrolled in our study. We reviewed the demographics of the donors and the recipients' baseline information, survival rate, cause of death, and postoperative complications. All patients underwent follow-up, with a mean duration of $26.1{\pm}16.7months$. Results: Early death occurred in two patients (20%) due to septic shock. Late death occurred in three patients (38%) due to bronchiolitis obliterans (n=2) and septic shock (n=1), although these patients survived for 22, 28, and 42 months, respectively. The actuarial survival rates at one year, two years, and three years after HLT were 80%, 67%, and 53%, respectively. Conclusion: HLT is a procedure that is rarely performed in Korea, even in medical centers with large heart and lung transplant programs. In order to achieve acceptable clinical outcomes, it is critical to carefully choose the donor and the recipient and to be certain that all aspects of the transplant procedure are planned in advance with the greatest care.

Keywords

References

  1. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-64. https://doi.org/10.1056/NEJM198203113061001
  2. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report--2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33:1009-24. https://doi.org/10.1016/j.healun.2014.08.004
  3. Potter CD, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant 1995;14(1 Pt 1):59-65.
  4. Tierney A, Foster R, Ogella D. A perfusionist's role in lung transplant preservation. Perfusion 2004;19:351-7. https://doi.org/10.1191/0267659104pf767oa
  5. Huddleston CB, Richey SR. Heart-lung transplantation. J Thorac Dis 2014;6:1150-8.
  6. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014;33:127-33. https://doi.org/10.1016/j.healun.2013.10.022
  7. Deuse T, Sista R, Weill D, et al. Review of heart-lung transplantation at Stanford. Ann Thorac Surg 2010;90:329-37. https://doi.org/10.1016/j.athoracsur.2010.01.023
  8. Novitzky D, Cooper DK, Rose AG, Reichart B. Acute isolated pulmonary rejection following transplantation of the heart and both lungs: experimental and clinical observations. Ann Thorac Surg 1986;42:180-4. https://doi.org/10.1016/S0003-4975(10)60514-0
  9. Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Ann Thorac Surg 2006;81:286-91. https://doi.org/10.1016/j.athoracsur.2005.08.010
  10. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 2003;22:1007-18. https://doi.org/10.1183/09031936.03.00039103
  11. Vos R, Vanaudenaerde BM, Verleden SE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 2011;37: 164-72. https://doi.org/10.1183/09031936.00068310
  12. Ross DJ, Lewis MI, Kramer M, Vo A, Kass RM. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. Chest 1997;112:1175-9. https://doi.org/10.1378/chest.112.5.1175
  13. Jaksch P, Scheed A, Keplinger M, et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012;31:950-7. https://doi.org/10.1016/j.healun.2012.05.002
  14. Fischer S, Hoeper MM, Bein T, et al. Interventional lung assist: a new concept of protective ventilation in bridge to lung transplantation. ASAIO J 2008;54:3-10. https://doi.org/10.1097/MAT.0b013e318161d6ec
  15. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support?: the US experience. J Thorac Cardiovasc Surg 2010;139:765-773.e1. https://doi.org/10.1016/j.jtcvs.2009.09.031
  16. Jayarajan SN, Taghavi S, Komaroff E, et al. Impact of extracorporeal membrane oxygenation or mechanical ventilation as bridge to combined heart-lung transplantation on short-term and long-term survival. Transplantation 2014;97: 111-5. https://doi.org/10.1097/TP.0b013e3182a860b8
  17. Baz MA, Palmer SM, Staples ED, Greer DG, Tapson VF, Davis DD. Lung transplantation after long-term mechanical ventilation: results and 1-year follow-up. Chest 2001;119:224-7. https://doi.org/10.1378/chest.119.1.224
  18. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:289-300.
  19. Enright S, Chatham K, Ionescu AA, Unnithan VB, Shale DJ. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. J Cyst Fibros 2007;6:384-90. https://doi.org/10.1016/j.jcf.2007.02.006

Cited by

  1. Safety study of autologous adult bone marrow derived mesenchymal stromal cells in idiopathic pulmonary fibrosis - Pilot data vol.4, pp.1, 2017, https://doi.org/10.1016/j.nhtm.2017.10.002
  2. Clinical Outcomes of Lung Transplantation: Experience at Asan Medical Center vol.51, pp.1, 2016, https://doi.org/10.5090/kjtcs.2018.51.1.22